Reintroduce intimacy into your relationship, and then the sex will come. Communicate and set boundaries. Tell your partner exactly what you want. If you want to cuddle and make out like teenagers, great! Make sure to let him know that, so he does not have expectations of sex. Let your partner know you want to, but you are not ready. Take those baby steps and allow your mind and body a chance to reconnect.
For those considering participating in a breast cancer clinical trial, it is important to understand what happens after the participant is no longer in the study. The study can end for some people before its planned duration is reached, or before the study’s endpoint is determined. Some participants may also be want to continue with a treatment after the study is over. All of these issues are important to review with study coordinators before beginning a clinical trial. The Informed Consent Document also provides information about leaving a study or what to expect after the study is over.
As October comes to a close, we can begin to say goodbye to a world awash in pink! We have been made aware of the risks for breast cancer. We’ve heard about ways to diagnose it that might be better than mammograms, and read about “groundbreaking” and “game changing” new treatments. This “pink cloud” often masks not only the realities of a breast cancer diagnosis but also how limited our research has been. Most breast cancer research is still done on laboratory rats and mice. And when we do study women, we still do not enroll significant numbers of women of color!
The Food and Drug Administration (FDA) has cleared a cooling cap—a device designed to reduce hair loss during chemotherapy—for use by patients with any kind of solid tumor. FDA initially cleared the device, the DigniCap® Scalp Cooling System, for patients with breast cancer in 2015.
Shockingly, worldwide cancer rates are predicted to rise even further, and that by the year 2020, 1-in-2 women and 1-in-3 men will be diagnosed with some form of cancer. It is so common already, in fact, that it getting cancer is more common than getting married or having a first baby. The cancer industrial complex is negligent in warning people who chemotherapy is now known to actually make some cancers spread and make some tumors more aggressive. Government and its myriad regulatory agencies work diligently to prevent access to natural or alternative cancer treatments, and doctors and the mainstream media give the impression that the causes of cancer are a mystery. In reality, one can significantly reduce the likelihood of getting cancer by making lifestyle changes, and according to a recently published study out of Canada found that the total proportion of cancer rates which can be attributed to lifestyle and environmental factors is quite high, nearing 41%.
Writers before me like Susan Sontag and Barbara Ehrenreich lived with breast cancer (and Sontag died from it), and both wrote about the dissonance of war metaphors in describing our disease. In war, we are taught, there are winners and losers. When breast cancer, a disease for which there is no known cure, progresses to our lymph nodes and shuts down our organs, have we as fighters failed?
It takes more than a pink ribbon to show a company really cares about women living with and at risk of breast cancer. Instead of taking steps to clean up their products and manufacturing process as part of their work to “create a breast cancer-free world,” Estée Lauder is congratulating themselves on distributing more than 150 million pink ribbons at their beauty counters and illuminating more than 1,000 landmarks around the world pink “to raise awareness.” They even hold the Guinness World Record for “Most Landmarks Illuminated for a Cause in 24 Hours.” But in our book, the only record they hold is longest running empty awareness campaign.
Bisphosphonates are commonly prescribed for the management of postmenopausal osteoporosis. “Preclinical studies have suggested that bisphosphonates could also exert some antitumor activity through an effect on tumor apoptosis, proliferation, invasion, or angiogenesis, which makes bisphosphonates an attractive class of drugs to be studied further for cancer prevention,” wrote study authors led by Agnès Fournier, PhD, of Université Paris-Sud in Paris. However, a large observational study of postmenopausal women found that bisphosphonate use, mostly oral, and likely prescribed for the management of osteoporosis, was not associated with decreased breast cancer risk. The authors concluded. “Our results therefore do not support the hypothesis that bisphosphonates could be effective for breast cancer prevention in postmenopausal women.”
You may be experiencing more than a clean home when you use many commercial cleaning products. That’s because there are countless harmful ingredients that should not be used. Here is a summary of some of the worst ingredients along with superior natural options.
The U.S. Food and Drug Administration has approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. Nerlynx is indicated for adult patients who have been previously treated with a regimen that includes the drug trastuzumab.
Researchers from 300 institutions around the world combined forces to discover 72 previously unknown gene mutations that lead to the development of breast cancer. Two studies describing their work published Monday in the journals Nature and Nature Genetics. The teams found that 65 of the newly identified genetic variants are common among women with breast cancer. The remaining seven mutations predispose women to developing a type of breast cancer known as estrogen-receptor-negative breast cancer, which doesn’t respond to hormonal therapies, such as the drug tamoxifen. The new discoveries add to previous research bringing the total number of known variants associated with breast cancer to nearly 180.
When Angelina Jolie publicly announced her double mastectomy four years ago, she was praised for possibly saving many women’s lives. But we know more today than we did then and experts now agree that too many women are undergoing unnecessary mastectomies – even some women with the “breast cancer genes.” You’ll be surprised by what we’ve learned.
On the first of October, the White House was lit up pink in honor of breast-cancer awareness. President Trump even released a statement pledging to “stand strong for those facing a breast cancer diagnosis.” Since then, the White House has not made another peep about breast cancer. Instead, the president has used the month to make several moves that, more than anything, show breast-cancer patients how little Trump cares for them. Or even thinks about them at all. He’s attacked an Affordable Care Act provision that makes insurance policies more affordable to low-income people, targeted environmental regulations, and singled out women’s health. And the month’s only half over.
The leading cause of death in breast cancer patients today is heart disease. Women in their 40s and 50s are experiencing heart failure and other cardiotoxicities after treatment with radiation, anthracyclines and HER2 receptor antagonists, noted Sandra Cuellar, PharmD, BCOP, at the 13th Annual Conference of the Hematology/Oncology Pharmacy Association.
After more than 30 years of widespread promotion of routine breast cancer screening for women at average risk, an undeniable body of research shows the significant harms and limited benefits of population-based screening. The truth is that widespread mammography screening has failed to dramatically reduce the number of deaths from breast cancer. Last week, a new study in the New England Journal of Medicine added to the compelling evidence that for a majority of asymptomatic women at average risk of breast cancer, the harms of screening may outweigh the benefit.
There are no pros and cons to this situation, it’s just shit. Period. People often say, “Well, you could walk out of your front door and get knocked down by a bus!” Guess what, being diagnosed with cancer makes you feel exactly like that! Nevertheless, one can’t help but become philosophical when faced with this kind of adversity. I’ve even gained the prestigious nickname ‘the voice of reason’, and as a result I’ve managed to find eight positive outcomes from having breast cancer. Unbelievable, I know, yet true.
Based on the risks that phthalates pose to women and children, many of these chemicals have been banned for use in children’s toys and childcare articles by the Consumer Product Safety Commission. But that’s little protection for pregnant women. Europe has already prohibited all phthalates from use in plastic food contact materials for fatty foods, including dairy products, except for three phthalates whose use has been highly restricted. In contrast, the U.S. Food and Drug Administration has failed to take action in response to growing concern and scientific consensus.
Doctors have been using the American Joint Committee on Cancer TNM system when diagnosing breast cancer. It was based on the size of the tumor, where the cancer had reached nearby lymph nodes and whether the cancer had metastasized (or spread). In that system, there are typically four stages of breast cancer, with the first stage meaning the cancer is contained in the breast and the fourth stage signifying that the cancer has spread to multiple other parts of the body. Stage IV breast cancer has been considered difficult to cure. The new staging system will now add a fourth factor to the TNM system: Genomic testing, which will look at the DNA of the tumor.
It’s complicated. Your clothing is never made solely out of just cotton or polyester. Every single fabric has some form of processing. It may be preshunk cotton, or superwash merino. It may be bleached. It’s almost always dyed. And nowadays clothing comes in all kinds of high-tech variations: UV protective, bug repellant, wrinkle-free, stain resistant, antimicrobial, and so on. Even pure cotton can be grown with pesticides.
The National Council on Radiation Protection and Measurements (NCRP) has confirmed the risks of radiation therapy to treat cancer. In a report, the council noted that as the number of cancer survivors tripled in the last 40 years, more survivors have developed heart problems or a new, different cancer likely related to radiation exposure during treatment for the first cancer.